nodes	percent_of_prediction	percent_of_DWPC	metapath
Paramethadione—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.176	0.199	CbGbCtD
Paramethadione—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.117	0.133	CbGbCtD
Paramethadione—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.108	0.122	CbGbCtD
Paramethadione—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.108	0.122	CbGbCtD
Paramethadione—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0828	0.0936	CbGbCtD
Paramethadione—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0818	0.0924	CbGbCtD
Paramethadione—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.056	0.0632	CbGbCtD
Paramethadione—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0534	0.0603	CbGbCtD
Paramethadione—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0476	0.0537	CbGbCtD
Paramethadione—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0279	0.0315	CbGbCtD
Paramethadione—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0264	0.0298	CbGbCtD
Paramethadione—CACNA1G—Nicotine Activity on Chromaffin Cells—CHRNA3—chronic obstructive pulmonary disease	0.026	0.227	CbGpPWpGaD
Paramethadione—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00367	0.032	CbGpPWpGaD
Paramethadione—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00325	0.0283	CbGpPWpGaD
Paramethadione—CACNA1H—Corticotropin-releasing hormone—RAPGEF3—chronic obstructive pulmonary disease	0.00312	0.0272	CbGpPWpGaD
Paramethadione—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00266	0.0232	CbGpPWpGaD
Paramethadione—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00226	0.0197	CbGpPWpGaD
Paramethadione—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—chronic obstructive pulmonary disease	0.00209	0.0183	CbGpPWpGaD
Paramethadione—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.00205	0.0179	CbGpPWpGaD
Paramethadione—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00184	0.016	CbGpPWpGaD
Paramethadione—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—chronic obstructive pulmonary disease	0.0017	0.0149	CbGpPWpGaD
Paramethadione—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.00167	0.0146	CbGpPWpGaD
Paramethadione—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.00164	0.0143	CbGpPWpGaD
Paramethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—HDAC2—chronic obstructive pulmonary disease	0.00161	0.014	CbGpPWpGaD
Paramethadione—CYP2E1—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.0015	0.0131	CbGpPWpGaD
Paramethadione—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.00149	0.013	CbGpPWpGaD
Paramethadione—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00135	0.0118	CbGpPWpGaD
Paramethadione—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.00133	0.0116	CbGpPWpGaD
Paramethadione—CYP2E1—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00125	0.0109	CbGpPWpGaD
Paramethadione—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.00121	0.0106	CbGpPWpGaD
Paramethadione—CYP2E1—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00121	0.0105	CbGpPWpGaD
Paramethadione—CYP2E1—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.00109	0.0095	CbGpPWpGaD
Paramethadione—CYP2C8—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00108	0.00946	CbGpPWpGaD
Paramethadione—CYP2C8—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00104	0.00909	CbGpPWpGaD
Paramethadione—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.00103	0.00901	CbGpPWpGaD
Paramethadione—CYP2E1—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000912	0.00795	CbGpPWpGaD
Paramethadione—CYP2C9—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000883	0.0077	CbGpPWpGaD
Paramethadione—CYP2E1—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000877	0.00764	CbGpPWpGaD
Paramethadione—CACNA1H—Corticotropin-releasing hormone—TLR4—chronic obstructive pulmonary disease	0.000851	0.00743	CbGpPWpGaD
Paramethadione—CYP2C9—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000849	0.0074	CbGpPWpGaD
Paramethadione—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000821	0.00716	CbGpPWpGaD
Paramethadione—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000801	0.00699	CbGpPWpGaD
Paramethadione—CYP2C8—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000788	0.00687	CbGpPWpGaD
Paramethadione—CYP2C8—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000758	0.00661	CbGpPWpGaD
Paramethadione—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000696	0.00607	CbGpPWpGaD
Paramethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—chronic obstructive pulmonary disease	0.000667	0.00582	CbGpPWpGaD
Paramethadione—CACNA1H—Corticotropin-releasing hormone—NOS3—chronic obstructive pulmonary disease	0.000651	0.00568	CbGpPWpGaD
Paramethadione—CYP2E1—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000644	0.00562	CbGpPWpGaD
Paramethadione—CYP2C9—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000641	0.00559	CbGpPWpGaD
Paramethadione—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000633	0.00552	CbGpPWpGaD
Paramethadione—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000617	0.00538	CbGpPWpGaD
Paramethadione—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000606	0.00529	CbGpPWpGaD
Paramethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—chronic obstructive pulmonary disease	0.000603	0.00526	CbGpPWpGaD
Paramethadione—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000582	0.00508	CbGpPWpGaD
Paramethadione—CACNA1I—NCAM signaling for neurite out-growth—IL6—chronic obstructive pulmonary disease	0.000579	0.00505	CbGpPWpGaD
Paramethadione—CACNA1H—Corticotropin-releasing hormone—CXCL8—chronic obstructive pulmonary disease	0.000578	0.00504	CbGpPWpGaD
Paramethadione—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000577	0.00503	CbGpPWpGaD
Paramethadione—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00056	0.00488	CbGpPWpGaD
Paramethadione—CYP2E1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000533	0.00465	CbGpPWpGaD
Paramethadione—CYP2C8—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000521	0.00454	CbGpPWpGaD
Paramethadione—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000521	0.00454	CbGpPWpGaD
Paramethadione—CYP2E1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000514	0.00448	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000511	0.00445	CbGpPWpGaD
Paramethadione—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000506	0.00441	CbGpPWpGaD
Paramethadione—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000485	0.00423	CbGpPWpGaD
Paramethadione—CYP2E1—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000468	0.00408	CbGpPWpGaD
Paramethadione—CYP2C8—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000461	0.00402	CbGpPWpGaD
Paramethadione—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00046	0.00401	CbGpPWpGaD
Paramethadione—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00045	0.00393	CbGpPWpGaD
Paramethadione—CYP2C8—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000444	0.00388	CbGpPWpGaD
Paramethadione—CACNA1H—Corticotropin-releasing hormone—TGFB1—chronic obstructive pulmonary disease	0.000431	0.00375	CbGpPWpGaD
Paramethadione—CACNA1G—NCAM signaling for neurite out-growth—IL6—chronic obstructive pulmonary disease	0.000427	0.00372	CbGpPWpGaD
Paramethadione—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000424	0.0037	CbGpPWpGaD
Paramethadione—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000423	0.00369	CbGpPWpGaD
Paramethadione—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000422	0.00368	CbGpPWpGaD
Paramethadione—CACNA1H—NCAM signaling for neurite out-growth—IL6—chronic obstructive pulmonary disease	0.000413	0.0036	CbGpPWpGaD
Paramethadione—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000407	0.00355	CbGpPWpGaD
Paramethadione—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000381	0.00332	CbGpPWpGaD
Paramethadione—CYP2C8—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000379	0.0033	CbGpPWpGaD
Paramethadione—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000378	0.0033	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000377	0.00328	CbGpPWpGaD
Paramethadione—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000375	0.00327	CbGpPWpGaD
Paramethadione—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000374	0.00326	CbGpPWpGaD
Paramethadione—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000366	0.0032	CbGpPWpGaD
Paramethadione—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000365	0.00318	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000365	0.00318	CbGpPWpGaD
Paramethadione—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000362	0.00315	CbGpPWpGaD
Paramethadione—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000327	0.00285	CbGpPWpGaD
Paramethadione—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000323	0.00282	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.000317	0.00277	CbGpPWpGaD
Paramethadione—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000308	0.00269	CbGpPWpGaD
Paramethadione—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000307	0.00268	CbGpPWpGaD
Paramethadione—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000299	0.00261	CbGpPWpGaD
Paramethadione—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000297	0.00259	CbGpPWpGaD
Paramethadione—CYP2E1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00027	0.00235	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—MMP9—chronic obstructive pulmonary disease	0.000267	0.00233	CbGpPWpGaD
Paramethadione—CYP2E1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000267	0.00233	CbGpPWpGaD
Paramethadione—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000266	0.00232	CbGpPWpGaD
Paramethadione—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000265	0.00231	CbGpPWpGaD
Paramethadione—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000263	0.00229	CbGpPWpGaD
Paramethadione—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000247	0.00216	CbGpPWpGaD
Paramethadione—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000242	0.00211	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—VEGFA—chronic obstructive pulmonary disease	0.00024	0.00209	CbGpPWpGaD
Paramethadione—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000239	0.00208	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.000234	0.00204	CbGpPWpGaD
Paramethadione—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000233	0.00203	CbGpPWpGaD
Paramethadione—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000231	0.00201	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.000227	0.00198	CbGpPWpGaD
Paramethadione—CYP2E1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000224	0.00196	CbGpPWpGaD
Paramethadione—CYP2E1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000221	0.00193	CbGpPWpGaD
Paramethadione—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000217	0.00189	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—EGFR—chronic obstructive pulmonary disease	0.000216	0.00188	CbGpPWpGaD
Paramethadione—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000216	0.00188	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—MMP9—chronic obstructive pulmonary disease	0.000197	0.00172	CbGpPWpGaD
Paramethadione—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000196	0.00171	CbGpPWpGaD
Paramethadione—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000194	0.00169	CbGpPWpGaD
Paramethadione—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000191	0.00167	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—MMP9—chronic obstructive pulmonary disease	0.000191	0.00166	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—MMP9—chronic obstructive pulmonary disease	0.000191	0.00166	CbGpPWpGaD
Paramethadione—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00019	0.00166	CbGpPWpGaD
Paramethadione—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000188	0.00164	CbGpPWpGaD
Paramethadione—CYP2E1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000187	0.00163	CbGpPWpGaD
Paramethadione—CYP2E1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000185	0.00161	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—VEGFA—chronic obstructive pulmonary disease	0.000177	0.00154	CbGpPWpGaD
Paramethadione—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000176	0.00153	CbGpPWpGaD
Paramethadione—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000173	0.00151	CbGpPWpGaD
Paramethadione—CYP2E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000172	0.0015	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—VEGFA—chronic obstructive pulmonary disease	0.000171	0.00149	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	0.000171	0.00149	CbGpPWpGaD
Paramethadione—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.00017	0.00148	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—IL6—chronic obstructive pulmonary disease	0.000166	0.00145	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000164	0.00143	CbGpPWpGaD
Paramethadione—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000163	0.00142	CbGpPWpGaD
Paramethadione—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000162	0.00141	CbGpPWpGaD
Paramethadione—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000161	0.0014	CbGpPWpGaD
Paramethadione—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000159	0.00139	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—EGFR—chronic obstructive pulmonary disease	0.000159	0.00139	CbGpPWpGaD
Paramethadione—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000158	0.00138	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	0.000157	0.00137	CbGpPWpGaD
Paramethadione—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000156	0.00136	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—EGFR—chronic obstructive pulmonary disease	0.000154	0.00134	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—EGFR—chronic obstructive pulmonary disease	0.000154	0.00134	CbGpPWpGaD
Paramethadione—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000149	0.0013	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—TNF—chronic obstructive pulmonary disease	0.000147	0.00128	CbGpPWpGaD
Paramethadione—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000147	0.00128	CbGpPWpGaD
Paramethadione—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000142	0.00124	CbGpPWpGaD
Paramethadione—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000141	0.00123	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—MMP9—chronic obstructive pulmonary disease	0.000141	0.00123	CbGpPWpGaD
Paramethadione—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000139	0.00121	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—MMP9—chronic obstructive pulmonary disease	0.000136	0.00119	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000133	0.00116	CbGpPWpGaD
Paramethadione—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000132	0.00115	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000131	0.00114	CbGpPWpGaD
Paramethadione—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.00013	0.00113	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	0.000126	0.0011	CbGpPWpGaD
Paramethadione—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000125	0.00109	CbGpPWpGaD
Paramethadione—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000124	0.00108	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—IL6—chronic obstructive pulmonary disease	0.000122	0.00107	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	0.000122	0.00107	CbGpPWpGaD
Paramethadione—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000121	0.00105	CbGpPWpGaD
Paramethadione—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000119	0.00104	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—IL6—chronic obstructive pulmonary disease	0.000119	0.00103	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—IL6—chronic obstructive pulmonary disease	0.000118	0.00103	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	0.000116	0.00101	CbGpPWpGaD
Paramethadione—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000115	0.001	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—EGFR—chronic obstructive pulmonary disease	0.000114	0.000991	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	0.000113	0.000988	CbGpPWpGaD
Paramethadione—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000113	0.000986	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	0.000112	0.000979	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—EGFR—chronic obstructive pulmonary disease	0.00011	0.00096	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—TNF—chronic obstructive pulmonary disease	0.000108	0.000944	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—TNF—chronic obstructive pulmonary disease	0.000105	0.000914	CbGpPWpGaD
Paramethadione—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000104	0.000908	CbGpPWpGaD
Paramethadione—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000103	0.000895	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	9.22e-05	0.000804	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—IL6—chronic obstructive pulmonary disease	8.73e-05	0.000761	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.69e-05	0.000758	CbGpPWpGaD
Paramethadione—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.68e-05	0.000757	CbGpPWpGaD
Paramethadione—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.56e-05	0.000747	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—IL6—chronic obstructive pulmonary disease	8.46e-05	0.000737	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	8.45e-05	0.000737	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	8.08e-05	0.000705	CbGpPWpGaD
Paramethadione—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.98e-05	0.000696	CbGpPWpGaD
Paramethadione—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.87e-05	0.000686	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.86e-05	0.000685	CbGpPWpGaD
Paramethadione—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.56e-05	0.000659	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.51e-05	0.000655	CbGpPWpGaD
Paramethadione—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.46e-05	0.00065	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	7.45e-05	0.000649	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	7.3e-05	0.000637	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.79e-05	0.000592	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.58e-05	0.000574	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.11e-05	0.000533	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	6.08e-05	0.000531	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	6.06e-05	0.000528	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	5.94e-05	0.000518	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.53e-05	0.000482	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.41e-05	0.000472	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.62e-05	0.000403	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	4.56e-05	0.000398	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.4e-05	0.000384	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	4.16e-05	0.000363	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.03e-05	0.000351	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.99e-05	0.000348	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	3.94e-05	0.000344	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	3.92e-05	0.000342	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.84e-05	0.000335	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.68e-05	0.000321	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.64e-05	0.000318	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	3.6e-05	0.000314	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.32e-05	0.000289	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.25e-05	0.000283	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	3.21e-05	0.00028	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.2e-05	0.000279	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.16e-05	0.000275	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.99e-05	0.000261	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.94e-05	0.000256	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	2.93e-05	0.000255	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.79e-05	0.000243	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.77e-05	0.000241	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.73e-05	0.000238	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.7e-05	0.000235	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.54e-05	0.000222	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.41e-05	0.00021	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.25e-05	0.000196	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.22e-05	0.000194	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.14e-05	0.000187	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	2.12e-05	0.000185	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.07e-05	0.00018	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.96e-05	0.000171	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.93e-05	0.000168	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	1.89e-05	0.000165	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.81e-05	0.000158	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.78e-05	0.000155	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	1.64e-05	0.000143	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	1.57e-05	0.000137	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.48e-05	0.000129	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.46e-05	0.000128	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.36e-05	0.000119	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	1.33e-05	0.000116	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.29e-05	0.000113	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	1.27e-05	0.000111	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	8.79e-06	7.67e-05	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	8.41e-06	7.33e-05	CbGpPWpGaD
